{"id":36730,"date":"2025-07-04T17:52:51","date_gmt":"2025-07-04T09:52:51","guid":{"rendered":"https:\/\/flcube.com\/?p=36730"},"modified":"2025-07-04T17:52:52","modified_gmt":"2025-07-04T09:52:52","slug":"thermo-fishers-oncomine-dx-express-test-approved-by-fda-as-companion-diagnostic-for-dizals-zegfrovy","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=36730","title":{"rendered":"Thermo Fisher’s Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal’s Zegfrovy"},"content":{"rendered":"\n

US-based Thermo Fisher Scientific Inc. (NYSE: TMO<\/a>) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192<\/a>) Zegfrovy (sunvozertinib) and in tumor profiling.<\/p>\n\n\n\n

Companion Diagnostic Utility<\/strong>
The Oncomine Dx Express Test provides a rapid and reliable method for identifying patients with non-small cell lung cancer (NSCLC) who harbor EGFR exon 20 insertion mutations. This approval facilitates earlier intervention and expands access to targeted treatment for patients eligible for Zegfrovy.<\/p>\n\n\n\n

Zegfrovy Background<\/strong>
Zegfrovy (sunvozertinib) is an oral, irreversible, and highly selective EGFR tyrosine kinase inhibitor (TKI) targeting multiple EGFR mutation subtypes. It was approved in China under priority review in August 2023 and received accelerated approval in the US earlier this week for the treatment of NSCLC patients with EGFR exon 20 insertion mutations.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from…<\/p>\n","protected":false},"author":1,"featured_media":36731,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[191,1261,15,981,523],"class_list":["post-36730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-dizal-pharmaceutical","tag-nyse-tmo","tag-product-approvals","tag-sha-688192","tag-thermo-fisher-scientific"],"yoast_head":"\nThermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=36730\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy\" \/>\n<meta property=\"og:description\" content=\"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=36730\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-04T09:52:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-04T09:52:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Thermo Fisher’s Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal’s Zegfrovy\",\"datePublished\":\"2025-07-04T09:52:51+00:00\",\"dateModified\":\"2025-07-04T09:52:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730\"},\"wordCount\":186,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0415.webp\",\"keywords\":[\"Dizal Pharmaceutical\",\"NYSE: TMO\",\"Product approvals\",\"SHA: 688192\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=36730#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=36730\",\"name\":\"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0415.webp\",\"datePublished\":\"2025-07-04T09:52:51+00:00\",\"dateModified\":\"2025-07-04T09:52:52+00:00\",\"description\":\"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=36730\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0415.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0415.webp\",\"width\":1080,\"height\":608,\"caption\":\"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36730#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher’s Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal’s Zegfrovy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy - Insight, China's Pharmaceutical Industry","description":"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=36730","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy","og_description":"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.","og_url":"https:\/\/flcube.com\/?p=36730","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-04T09:52:51+00:00","article_modified_time":"2025-07-04T09:52:52+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=36730#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=36730"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Thermo Fisher’s Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal’s Zegfrovy","datePublished":"2025-07-04T09:52:51+00:00","dateModified":"2025-07-04T09:52:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=36730"},"wordCount":186,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=36730#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","keywords":["Dizal Pharmaceutical","NYSE: TMO","Product approvals","SHA: 688192","Thermo Fisher Scientific"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=36730#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=36730","url":"https:\/\/flcube.com\/?p=36730","name":"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=36730#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=36730#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","datePublished":"2025-07-04T09:52:51+00:00","dateModified":"2025-07-04T09:52:52+00:00","description":"US-based Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. The test is authorized as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for China-based Dizal Pharmaceutical Co., Ltd\u2019s (SHA: 688192) Zegfrovy (sunvozertinib) and in tumor profiling.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=36730#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=36730"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=36730#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","width":1080,"height":608,"caption":"Thermo Fisher's Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal's Zegfrovy"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=36730#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher’s Oncomine Dx Express Test Approved by FDA as Companion Diagnostic for Dizal’s Zegfrovy"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0415.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=36730"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36730\/revisions"}],"predecessor-version":[{"id":36732,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36730\/revisions\/36732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/36731"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=36730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=36730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=36730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}